In the last decade, clinical mass spectrometry use cases are spreading rapidly. Therapeutic drug monitoring (TDM) is the practice of monitoring therapeutic efficacy and side effects when a patient is undergoing treatment. This is especially important in drug therapy regimes where there could be concerns about potentially toxic symptoms, drug interactions, or other serious issues. A/Prof Masamitsu Maekawa shares his extensive experience using clinical mass spectrometry for TDM usage in this talk at RED 2024.
Clinical mass spectrometry for therapeutic drug monitoring
![](https://labinsights.com/wp-content/uploads/2024/12/Clinical-mass-spectrometry-for-therapeutic-drug-monitoring_thumbnail.png)
Получите подписку на последние новости и обновления LabInsights
![](https://labinsights.com/wp-content/uploads/2024/08/subscribe_banner_img_mobile.jpg)
Другие материалы по этой же теме
Получите подписку на последние новости и обновления LabInsights
![](https://labinsights.com/wp-content/uploads/2024/08/subscribe_banner_img_mobile.jpg)
Читать далее
- C-Suite Perspectives, Event Coverage, Healthcare Transformation, Management, RED 2024
- C-Suite Perspectives, Leaders In Conversation, Management
- Healthcare Transformation, Management, Operations, Population Health Management
- Disease Area, Healthcare Transformation, Histopathology, Leaders In Conversation, Management, Oncology, Operations